药品名称LORABID
申请号050667产品号002
活性成分LORACARBEF市场状态停止上市
剂型或给药途径FOR SUSPENSION;ORAL规格200MG/5ML
治疗等效代码参比药物
批准日期1991/12/31申请机构KING PHARMACEUTICALS INC
化学类型New molecular entity (NME)审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
050667011APReview1997/11/04下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
050667022AP2001/09/27Labeling Revision
050667021AP2000/09/12Manufacturing Change or Addition
050667020AP2001/05/11Labeling Revision
050667019AP1999/11/08Manufacturing Change or Addition
050667018AP2000/10/05Labeling Revision
050667017AP1996/11/12Manufacturing Change or Addition
050667016AP1996/11/26Manufacturing Change or Addition
050667015AP1997/08/01Control Supplement
050667014AP1996/07/09Control Supplement
050667013AP1996/03/14Control Supplement
050667011AP1996/11/13Patient Population Altered
050667010AP1996/02/21Manufacturing Change or Addition
050667009AP1995/02/08Labeling Revision
050667008AP1995/02/08Labeling Revision
050667006AP1994/06/24Package Change
050667005AP1993/03/08Formulation Revision
050667004AP1993/09/02Manufacturing Change or Addition
050667003AP1993/02/16Manufacturing Change or Addition
050667002AP1992/12/30Labeling Revision
050667000AP1991/12/31Approval